• OPEN AN ACCOUNT
Indian Indices
Sensex
74,336.45 332.63
( 0.45%)
Global Indices
Nasdaq
52,102.03 -340.17
(-0.65%)
Dow Jones
7,605.54 -35.44
(-0.46%)
Hang Seng
63,783.20 299.10
(0.47%)
Nikkei 225
10,654.59 -42.98
(-0.40%)
Forex
USD-INR
95.28 -0.19
(-0.20%)
EUR-INR
110.09 -0.64
(-0.57%)
GBP-INR
128.59 -0.52
(-0.40%)
JPY-INR
0.62 0.00
(-0.70%)

EQUITY - MARKET SCREENER

Sun Pharmaceutical Industries Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
524715
INE044A01036
93.2373503
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
SUNPHARMA
138.28
440277.97
EPS(TTM)
Face Value()
Div & Yield %
13.27
1
0.87
 

Aditya Birla Capital forays into gold loan biz
Aug 20,2026

The NBFC business of Aditya Birla Capital announced its entry into the Gold Loan business, marking a strategic expansion of its secured lending portfolio. The Gold Loan offering complements its existing retail and MSME lending franchise, providing customers with a transparent, flexible and collateral-backed credit solution.

The Company has planned a phase-wise rollout of 200-300 dedicated Gold Loan branches by March 2027 across high-potential markets. Over the next three years, the ABCL-NBFC business aims to establish a network of around 1,000 Gold Loan branches, building a strong pan-India franchise and further strengthening its presence across the country.